No Data
No Data
TuHURA Biosciences Is Maintained at Buy by HC Wainwright & Co.
TuHURA Biosciences Analyst Ratings
Express News | Tuhura Biosciences, Inc. : H.c. Wainwright Cuts Target Price to $12 From $13
Express News | TuHURA Biosciences Shares Are Trading Higher on Possible Continued Strength After the Company Reported a Year-over-year Increase in FY24 EPS Results Yesterday
Express News | TuHURA Biosciences FY24 EPS ($1.21) Up From ($2.47) YoY
Express News | Tuhura Biosciences, Inc. Reports Financial Results for Fiscal Year 2024 and Provides Corporate Update